Further investigation of the effect of framework catenation on hydrogen uptake in metal-organic frameworks

Hydrogen-sorption studies have been carried out for the catenation isomer pairs of PCN-6 and PCN-6' (both have the formula of Cu(3)(TATB)(2), where TATB represents 4,4',4'-s-triazine-2,4,6-triyl-tribenzoate with a formula of C(24)H(12)N(3)O(6)). Inelastic neutron scattering (INS) studies reveal that the initial sites occupied by adsorbed H(2) are the open Cu centers of the paddlewheel units with comparable interaction energies in the two isomers. At high H(2) loadings, where the H(2) molecules adsorb mainly on or around the organic linkers, the interaction is found to be substantially stronger in catenated PCN-6 than in noncatenated PCN-6', leading to much higher H(2) uptake in the isomer with catenation. Hydrogen sorption measurements at pressures up to 50 bar demonstrate that framework catenation can be favorable for the enhancement of hydrogen adsorption. For example, the excess hydrogen uptake of PCN-6 is 72 mg/g (6.7 wt %) at 77 K/50 bar or 9.3 mg/g (0.92 wt %) at 298 K/50 bar, respectively, and that for PCN-6' is 42 mg/g (4.0 wt %) at 77 K/50 bar or 4.0 mg/g (0.40 wt %) at 298 K/50 bar. Importantly, PCN-6 exhibits a total hydrogen uptake of 95 mg/g (8.7 wt %) (corresponding to a total volumetric value of 53.0 g/L, estimated based on crystallographic density) at 77 K/50 bar and 15 mg/g (1.5 wt %) at 298 K/50 bar. Significantly, the expected usable capacity of PCN-6 is as high as 75 mg/g (or 41.9 g/L) at 77 K, if a recharging pressure of 1.5 bar is assumed.     

Syndiotactic polystyrene nanofibrils in silica nanotube reactors: understanding of synthesis with ultrahigh molecular weight

Nanofibrils of ultrahigh molecular weight syndiotactic polystyrene (sPS) have been synthesized in a silica nanotube reactor (SNTR) using a metallocene catalyst in conjunction with methylaluminoxane cocatalyst. Very thin sPS nanofibrils (<10 nm) grown at the catalytic sites on the pore walls aggregate to form intertwined, rope-like nanofibrils with 30-50 nm diameters, which further intertwine into even larger 200 nm diameter polymer nanofibrils. The extrusion of nanofibrils synthesized inside the SNTR was directly observed by scanning electron microscopy, and the individual SNTR containing a single polymer nanofibril was separated and observed by transmission electron microscopy. The sPS synthesized in the SNTR has ultrahigh molecular weight (Mw = 928,000 g/mol) with a large fraction of 2 000,000-5,000,000 g/mol molecular weight polymers.     

Capturing transient structures in the elimination reaction of haloalkane in solution by transient X-ray diffraction

This Communication reports simultaneous tracking of structural and kinetic information for the photoinduced elimination reaction of 1,2-diiodotetrafluoroethane in solution by transient X-ray diffraction. The transient structure of .CF2CF2I is determined to be a classical mixture whereas .CH2CH2I is bridged. Compared with the gas phase reaction, the secondary dissociation of .CF2CF2I into C2F4 and I is slowed down by a factor of 6 in solution. Transient X-ray diffraction offers a complementary method for capturing transient structures in solution which might be invisible or "optically silent" in time-resolved optical spectroscopy.     

Enhancement of solubility, dissolution and bioavailability of ibuprofen in solid dispersion systems

To improve its solubility, dissolution, and bioavailability; Ibuprofen-polyethylene glycol 8000 (PEG 8000) solid dispersions (SDs) with different drug loadings were prepared, characterized by scanning electron microscopy (SEM) and differential scanning calorimetry (DSC), and evaluated for solubility, in-vitro release, and oral bioavailability of ibuprofen in rats. Loss of individual surface properties during melting and solidification as revealed by SEM micrographs indicated the formation of effective SDs. Absence or shifting towards the lower melting temperature of the drug peak in SDs and physical mixtures in DSC study indicated the possibilities of drug-polymer interactions. Quicker release of ibuprofen from SDs in rat intestine resulted in a significant increase in AUC and C(max), and a significant decrease in T(max) over pure ibuprofen. Preliminary results of this study suggested that the preparation of ibuprofen SDs using PEG 8000 as a meltable hydrophilic polymer carrier could be a promising approach to improve solubility, dissolution and bioavailability of ibuprofen.     

A novel solution-processible heterodinuclear AlIII/IrIII complex for host-dopant assembly OLEDs

A discrete heterodinuclear Al (III)/Ir (III) complex shows bright-orange light emission when used as an active layer in host-dopant assembly organic light-emitting diodes based on a solution process.     

Significance of charge‐dipolar moiety interaction: Computational study of cyanospherands

Cyanospherands (CN‐spherands) are highly preorganized hosts which bind cations. Density functional theory calculations were used to investigate the complexation between cyanospherands and alkali metal ions (Li⁺, Na⁺, and K⁺). CN8‐spherand undergoes significant shape change upon complexation, i.e., the oval free host becomes spherical when complexed with cations. All cationic guests prefer external binding to encapsulation in spite of spherically well organized charged moieties and the spacious cavity of hosts. The ion‐dipolar moiety interaction has been found to be a decisive factor for the preference for external binding. This demonstrates the importance of ion‐dipolar moiety orientations as well as the host‐guest size complementarity, to design novel ionophores. © 2007 Wiley Periodicals, Inc. Int J Quantum Chem, 2008     

Mealworm Oil (MWO) Enhances Wound Healing Potential through the Activation of Fibroblast and Endothelial Cells

Mealworm and mealworm oil (MWO) have been reported to affect antioxidant, anti-coagulation, anti-adipogenic and anti-inflammatory activities. However, the function of MWO in wound healing is still unclear. In this study, we found that MWO induced the migration of fibroblast cells and mRNA expressions of wound healing factors such as alpha-smooth muscle actin (α-SMA), collagen-1 (COL-1) and vascular endothelial growth factor (VEGF) in fibroblast cells. The tube formation and migration of endothelial cells were promoted through the activation of VEGF/VEGF receptor-2 (VEGFR-2)-mediated downstream signals including AKT, extracellular signal-regulated kinase (ERK) and p38 by MWO-stimulated fibroblasts for angiogenesis. Moreover, we confirmed that MWO promoted skin wound repair by collagen synthesis, re-epithelialization and angiogenesis in an in vivo excisional wound model. These results demonstrate that MWO might have potential as a therapeutic agent for the treatment of skin wounds.     

Phloridzin Acts as an Inhibitor of Protein-Tyrosine Phosphatase MEG2 Relevant to Insulin Resistance

Inhibition of the megakaryocyte protein tyrosine phosphatase 2 (PTP-MEG2, also named PTPN9) activity has been shown to be a potential therapeutic strategy for the treatment of type 2 diabetes. Previously, we reported that PTP-MEG2 knockdown enhances adenosine monophosphate activated protein kinase (AMPK) phosphorylation, suggesting that PTP-MEG2 may be a potential antidiabetic target. In this study, we found that phloridzin, isolated from Ulmus davidiana var. japonica, inhibits the catalytic activity of PTP-MEG2 (half-inhibitory concentration, IC₅₀ = 32 ± 1.06 μM) in vitro, indicating that it could be a potential antidiabetic drug candidate. Importantly, phloridzin stimulated glucose uptake by differentiated 3T3-L1 adipocytes and C2C12 muscle cells compared to that by the control cells. Moreover, phloridzin led to the enhanced phosphorylation of AMPK and Akt relevant to increased insulin sensitivity. Importantly, phloridzin attenuated palmitate-induced insulin resistance in C2C12 muscle cells. We also found that phloridzin did not accelerate adipocyte differentiation, suggesting that phloridzin improves insulin sensitivity without significant lipid accumulation. Taken together, our results demonstrate that phloridzin, an inhibitor of PTP-MEG2, stimulates glucose uptake through the activation of both AMPK and Akt signaling pathways. These results strongly suggest that phloridzin could be used as a potential therapeutic candidate for the treatment of type 2 diabetes.     

Kinetic modeling of charge-transfer quenching in the CP29 minor complex

We performed transient absorption (TA) measurements on CP29 minor light-harvesting complexes that were reconstituted in vitro with either violaxanthin (Vio) or zeaxanthin (Zea) and demonstrate that the Zea-bound CP29 complexes exhibit charge-transfer (CT) quenching that has been correlated with the energy-dependent quenching (qE) in higher plants. Simulations of the difference TA kinetics reveal two-phase kinetics for intracomplex energy transfer to the CT quenching site in CP29 complexes, with a fast <500 fs component and a approximately 6 ps component. Specific chlorophyll sites within CP29 are identified as likely locations for CT quenching. We also construct a kinetic model for CT quenching during qE in an intact system that incorporates CP29 as a CT trap and show that the model is consistent with previous in vivo measurements on spinach thylakoid membranes. Finally, we compare simulations of CT quenching in thylakoids with those of the individual CP29 complexes and propose that CP29 rather than LHCII is a site of CT quenching.     

Characterization of a novel anti-human TNF-alpha murine monoclonal antibody with high binding affinity and neutralizing activity

In order to develop an anti-human TNF-alpha mAb, mice were immunized with recombinant human TNF-alpha. A murine mAb, TSK114, which showed the highest binding activity for human TNF-alpha was selected and characterized. TSK114 specifically bound to human TNF-alpha without cross-reactivity with the homologous murine TNF-alpha and human TNF-beta. TSK114 was found to be of IgG1 isotype with kappa light chain. The nucleotide sequences of the variable regions of TSK114 heavy and light chains were determined and analyzed for the usage of gene families for the variable (V), diversity (D), and joining (J) segments. Kinetic analysis of TSK114 binding to human TNF-alpha by surface plasmon resonance technique revealed a binding affinity (K(D)) of approximately 5.3 pM, which is about 1,000- and 100-fold higher than those of clinically relevant infliximab (Remicade) and adalimumab (Humira) mAbs, respectively. TSK114 neutralized human TNF-alpha-mediated cytotoxicity in proportion to the concentration, exhibiting about 4-fold greater efficiency than those of infliximab and adalimumab in WEHI 164 cells used as an in vitro model system. These results suggest that TSK114 has the potential to be developed into a therapeutic TNF-alpha-neutralizing antibody with picomolar affinity.